Drug intelligence / Profile preview

striatin

Development stage: Phase 3
Modality: Recombinant Proteins and Enzymes
Administration: Oral

Overview

Striatin, derived from snakehead fish extract, is a bioactive fraction used as a nutritional and lactation supplement. It is being investigated for its potential to improve nutritional status, reduce intestinal inflammation, and stimulate breast milk production. The extract contains striatin protein, a multifunctional scaffold protein known to modulate kinases, phosphatases, and calcium-dependent pathways, playing a role in cellular signaling and various biological processes.

Brand names: Inbumin Forte
Other names: channa striata extractsnakehead fish extractstriatin bioactive fraction

Beyond the preview

Go deeper on striatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on striatin.

Explore the full profile